Program Snapshot

Many common and rare diseases are caused by changes to the genetic code. Genome editing technologies present an exciting prospect for treatments and possibly even cures for these diseases. The NIH Common Fund’s Somatic Cell Genome Editing program aims to develop quality tools to perform effective and safe genome editing in human patients. These research tools will be made widely available to the research community to reduce the time and cost required to develop new therapies.

This page last reviewed on December 4, 2017